J. Ostrove

发表

Acquisition of genital herpes from an asymptomatic sexual partner.

J. Rooney, S. Straus, J. Felser, 1986, The New England journal of medicine.

Detection and characterization of latent HSV RNA by in situ and northern blot hybridization in guinea pigs.

K. Hartog, R. Burke, J. Ostrove, 1991, Virology.

Cell lines containing varicella-zoster virus open reading frame 62 and expressing the "IE" 175 protein complement ICP4 mutants of herpes simplex virus type 1

P. Kinchington, S. Straus, G. Inchauspé, 1988, Journal of virology.

Trans-activation of the human immunodeficiency virus long terminal repeat sequence by DNA viruses.

H. Gendelman, P. Howley, M. Martin, 1986, Proceedings of the National Academy of Sciences of the United States of America.

Varicella-Zoster Virus Infections: Biology, Natural History, Treatment, and Prevention

M. Sawyer, G. Inchauspé, S. Straus, 1988 .

Activation of the human immunodeficiency virus long terminal repeat by herpes simplex virus type 1 is associated with induction of a nuclear factor that binds to the NF-kappa B/core enhancer sequence

H. Gendelman, E. Duh, E. E. Max, 1988, Journal of virology.

Effect of Oral Acyclovir Treatment on Symptomatic and Asymptomatic Virus Shedding in Recurrent Genital Herpes

C. Hallahan, J. Rooney, M. Seidlin, 1989, Sexually transmitted diseases.

Latent herpes simplex virus in human trigeminal ganglia. Detection of an immediate early gene "anti-sense" transcript by in situ hybridization.

J. Smialek, S. Straus, J. Ostrove, 1987, The New England journal of medicine.

Progressive encephalitis three months after resolution of cutaneous zoster a patient with AIDS

B. Kleinschmidt-DeMasters, S. Straus, D. Cohn, 1986, Annals of neurology.

Development of an improved product enhanced reverse transcriptase assay.

R. Bird, J. Ostrove, A. Chang, 1997, Journal of virological methods.

Results of MDR-1 vector modification trial indicate that granulocyte/macrophage colony-forming unit cells do not contribute to posttransplant hematopoietic recovery following intensive systemic therapy.

P. Thall, G. Hortobagyi, R. Giles, 1996, Proceedings of the National Academy of Sciences of the United States of America.

Viral antigen stimulation of the production of human monokines capable of regulating HIV1 expression.

A. Fauci, J. Ostrove, B. Fernie, 1989, Journal of immunology.

Molecular biology of varicella zoster virus.

J. Ostrove, 1990, Advances in virus research.

Molecular analysis of the pyrimidine deoxyribonucleoside kinase gene of wild-type and acyclovir-resistant strains of varicella-zoster virus.

M. Sawyer, S. Straus, G. Inchauspé, 1988, The Journal of general virology.

Inhibition of adenovirus-transformed cell oncogenicity by adeno-associated virus.

K. Berns, J. Ostrove, D. Duckworth, 1981, Virology.

Differential regulation by varicella-zoster virus (VZV) and herpes simplex virus type-1 trans-activating genes.

J. Ostrove, G. Inchauspe, 1989, Virology.

Mapping of two varicella-zoster virus-encoded genes that activate the expression of viral early and late genes.

S. Nagpal, J. Ostrove, G. Inchauspe, 1989, Virology.

Trans-activation ofthehumanimmunodeficiency virus long terminal repeat sequence byDNA viruses (acquired immunodeficiency syndrome/virus coinfection/tat gene)

J. Ostrove, Malcolma . Martin, 1986 .

Varicella-zoster virus infection of human astrocytes, Schwann cells, and neurons.

J. Assouline, E. Major, M. Levin, 1990, Virology.

Chemotherapy immediately following autologous stem-cell transplantation in patients with advanced breast cancer.

S. Heimfeld, M. Andreeff, R. Giles, 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

Phenelzine in the treatment of aphthous ulcers of the mouth.

M. Sawyer, J. Rooney, S. Straus, 1985 .

Host species and strain differences affect the ability of an HSV-1 ICP0 deletion mutant to establish latency and spontaneously reactivate in vivo.

E. Romanowski, J. Ostrove, Y. Gordon, 1990, Virology.

Herpes simplex virus type 1 transcription is not detectable in quiescent human stromal keratitis by in situ hybridization.

R. D. Stulting, J. Pepose, S. Straus, 1993, Investigative ophthalmology & visual science.

Adenovirus early region 1b gene function required for rescue of latent adeno-associated virus.

K. Berns, J. Ostrove, 1980, Virology.

Patterns of gene expression and sites of latency in human nerve ganglia are different for varicella-zoster and herpes simplex viruses.

S. Straus, J. Ostrove, K. Croen, 1988, Proceedings of the National Academy of Sciences of the United States of America.

Directionality and further mapping of varicella zoster virus transcripts.

W. Reinhold, S. Straus, J. Ostrove, 1988, Virus research.

A rapid and simple procedure to detect the presence of MVM in conditioned cell fluids or culture media.

R. Bird, J. Ostrove, S. Havas, 1997, Biologicals : journal of the International Association of Biological Standardization.

Varicella-zoster virus complements herpes simplex virus type 1 temperature-sensitive mutants

S. Straus, J. Felser, J. Ostrove, 1987, Journal of virology.

Putative glycoprotein gene of varicella-zoster virus with variable copy numbers of a 42-base-pair repeat sequence has homology to herpes simplex virus glycoprotein C

P. Kinchington, S. Straus, W. Ruyechan, 1986, Journal of virology.

Mapping of the varicella zoster virus deoxypyrimidine kinase gene and preliminary identification of its transcript.

M. Sawyer, S. Straus, J. Felser, 1986, Virology.

Transcription mapping of the varicella-zoster virus genome

W. Reinhold, C. Fan, S. Straus, 1985, Journal of virology.

Characterization of herpes simplex virus type 2 latency-associated transcription in human sacral ganglia and in cell culture.

S. Straus, J. Ostrove, K. Croen, 1991, The Journal of infectious diseases.

The nucleotide sequence, 5' end, promoter domain, and kinetics of expression of the gene encoding the herpes simplex virus type 2 latency-associated transcript

S. Straus, J. Ostrove, P. Krause, 1991, Journal of virology.

Detection and preliminary characterization of herpes simplex virus type 1 transcripts in latently infected human trigeminal ganglia

S. Straus, J. Ostrove, K. Croen, 1988, Journal of virology.

Comparison of manufacturing techniques for adenovirus production

D. Vacante, J. Ostrove, Paddy Iyer, 1999, Cytotechnology.

Structural and kinetic analyses of herpes simplex virus type 1 latency-associated transcripts in human trigeminal ganglia and in cell culture.

S. Straus, J. Ostrove, K. Croen, 1990, The Journal of clinical investigation.

Transactivation of the HIV-1 LTR by HSV-1 immediate-early genes.

D. Margolis, S. Straus, A. Rabson, 1992, Virology.

Activation of the human immunodeficiency virus by herpes simplex virus type 1

H. Gendelman, J. Leonard, A. Rabson, 1987, Journal of virology.

Stimulation of RNA Synthesis in L-929 Cells by Rabbit Tumor Necrosis Factor 1

G. Gifford, J. Ostrove, 1979, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

MOLECULAR HYBRIDIZATION TECHNIQUES AND POLYMERASE CHAIN REACTION (PCR) AS METHODS FOR SAFETY ASSESSMENT OF ANIMAL CELLS USED IN BIOPHARMACEUTICAL PRODUCTION

N. Patel, D. Vacante, W. Walsh, 1992 .

Characterization of a potent varicella-zoster virus-encoded trans-repressor

S. Nagpal, J. Ostrove, Sunil Nagpal, 1991, Journal of virology.

Initiation of adenovirus DNA replication: detection of covalent complexes between nucleotide and the 80-kilodalton terminal protein

M. Challberg, T. Kelly, J. Ostrove, 1982, Journal of virology.

In vitro complementation as an assay for purification of adenovirus DNA replication proteins.

T. Kelly, J. Ostrove, J. Williams, 1983, Proceedings of the National Academy of Sciences of the United States of America.

HSV-1 activation of HIV-1 transcription is augmented by a cellular protein that binds near the initiator element.

D. Margolis, S. Straus, J. Ostrove, 1993, Virology.

Varicella-Zoster Virus Infections

M. Sawyer, S. Straus, J. Felser, 2020 .

The Transfer of Technology from the Laboratory to the Clinic: In Process Controls and Final Product Testing

J. Ostrove, F. Borellini, 2001 .

Viral shedding and biodistribution of G207, a multimutated, conditionally replicating herpes simplex virus type 1, after intracerebral inoculation in aotus.

R. Martuza, S. Rabkin, T. Todo, 2000, Molecular therapy : the journal of the American Society of Gene Therapy.

A phase1 study of stereotactic gene delivery of AAV2-NGF for Alzheimer's disease

A. Fleisher, S. Potkin, R. Bakay, 2014, Alzheimer's & Dementia.

Research Article A phase1 study of stereotactic gene delivery of AAV2-NGF for Alzheimer's disease

A. Fleisher, S. Potkin, R. Bakay, 2013 .

Advancing neurotrophic factors as treatments for age-related neurodegenerative diseases: developing and demonstrating “clinical proof-of-concept” for AAV-neurturin (CERE-120) in Parkinson's disease

R. Bartus, T. Baumann, J. Ostrove, 2013, Neurobiology of Aging.

Issues regarding gene therapy products for Parkinson's disease: the development of CERE-120 (AAV-NTN) as one reference point.

M. Tuszynski, J. Kordower, R. Bartus, 2007, Parkinsonism & related disorders.

Structural and Kinetic Analyses of Herpes Simplex Virus Type I Latency-associated Transcripts in Human Trigeminal Ganglia and in Cell Culture

S. Straus, J. Ostrove, K. Croen, 2022 .

Issues regarding gene therapy products for Parkinson's disease: the development of CERE-120 (AAV-NTN) as one reference point.

M. Tuszynski, J. Kordower, R. Bartus, 2007, Parkinsonism & related disorders.